The 17th Invest in ME Research International ME Conference (IIMEC17) took place on May 30, 2025, in Cambridge, United Kingdom, marking the final event of International ME Conference Week 2025—a series of collaborative events featuring workshops, strategic meetings, and scientific
Today, we are pleased to share a new publication, Steroid Dynamics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Case-Control Study using Ultra Performance Supercritical Fluid Chromatography Tandem Mass Spectrometry. The Heart of the Matter OMF’s research centers in Uppsala and Melbourne
The Director of OMF’s Ronald G. Tompkins Harvard ME/CFS Collaboration, Dr. David Systrom, recently attended the International ME/CFS Conference 2025 held in Berlin, Germany. As part of the conference, he gave two presentations—one on circulatory dysfunction, and another on a
We’re excited to share a new publication from OMF’s Collaborative Center at Montreal titled: “SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.” The Heart of the Matter The team at OMF’s Collaborative Center at Montreal published a paper
From the Desk of Dr. Danielle Meadows Vice President of Research Programs & Operations In the past, I’ve shared some information about the peer-review publication process—the last stage of the research process—and the concept of a preprint. We recognize that
What is an IRB or Ethics Board? From the Desk of Dr. Danielle Meadows Vice President of Research Programs & Operations The IRB plays a central role in the first stage of the research process—linked here again if you missed it—so
From the Desk of Dr. Danielle MeadowsVice President of Research Programs & Operations Today, I’m happy to share another update on a study that I introduced back in November 2024 in an interview with Dr. Systrom. The study is still
Today, we’re sharing an update on important developments in ME/CFS research — work that is steadily improving our understanding of the biology behind this complex and often life-altering condition. Whether a person’s ME/CFS began decades ago or more recently, the
From the Desk of Dr. Danielle Meadows, Vice President of Research Programs & Operations In the fall of 2024, I introduced to you all an overview of the research process, where studies typically move through four main stages: Study Design,
In May, I had the privilege of attending the 2025 Invest in ME Research International Conference in Cambridge, UK, along with OMF’s research Directors. This annual event brings together scientists, clinicians, and advocates committed to advancing ME/CFS and Long COVID
Statistics 101 From the Desk of Dr. Danielle Meadows Vice President of Research Programs & Operations A few months ago, I started talking about evaluating research studies by going through what it means to be a well-powered study. As part
We’re pleased to share a new publication by Jonas Bergquist, MD, PhD, and colleagues: “Comprehensive transcriptome assessment in PBMC of post-COVID patients at two years after a mild COVID infection reveals upregulation of JAK/STAT signaling and chronic inflammation.” The Heart of
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then email or call OMF at 650-242-8669 to notify us of your donation or with any questions.
